Renal stone disease: Causes, evaluation and medical treatment

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 4, 2006, Pages 823-831

  Heilberg, Ita Pfeferman ^a   Schor, Nestor ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Calcium; Hypercalciuria; Kidney stones; Nephrolithiasis; Osteopenia; Oxalate

Indexed keywords

EID: 33751241724     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302006000400027     Document Type: Review

References (66)

1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 2003;63(5):1817-23.
2. Moe OW. Kidney stones: Pathophysiology and medical management. Lancet 2006;367:333-44.
3. Pak CYC, Resnick MI, Preminger GM. Ethnic and geographic diversity of stone disease. Urology 1997;50(4):504-7.
4. st International Consultation on Stone Disease). Editions 21. France: Health Publications, 2003; pp. 61-4.
5. Trinchieri A, Ostini F, Nespoli R, Rovera F, Montanari E, Zanetti G. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol 1999;162(1):27-30.
6. Sutherland JW, Parks JH, Coe FL. Recurrence after a single renal stone in a community practice. Miner Electrolyte Metab 1985;11(4):267-9.
7. Li J, Kennedy D, Levine M, Kumar A, Mullen J. Absent hematuria and expensive computerized tomography: case characteristics of emergency urolithiasis. J Urol 2001;165(3):782-4.
8. Abramson S, Walders N, Applegate KE, Gilkeson RC, Robbin MR. Impact in the emergency department of unenhanced CT on diagnostic confidence and therapeutic efficacy in patients with suspected renal colic: a prospective survey. Am J Roentgenol 2000;175:1689-95.
9. Shokeir AA, Abdulmaaboud M. Prospective comparison of nonenhanced helical computerized tomography and doppler ultrasonography for the diagnosis of renal colic. J Urol 2001;165:1082-4.
10. Teichman JM. Clinical practice. Acute renal colic from ureteral calculus. N Engl J Med 2004;50(7):684-93.
11. Grisi G, Satcul F, Cuttin R, Rimondidi A, Meduri A, Dalla Palma L. Cost analysis of different protocols for imaging a patient with acute flank pain. Eur Radiol 2000;10:1620-7.
12. Gandolpho L, Sevillano M, Barbieri A, Ajzen S, Schor N, Ortiz V, et al. Scintigraphy and doppler ultrasonography for the evaluation of obstructive urinary calculi. Braz J Med Biol Res 2001;34(6):745-51.
13. Catalano O, Nunziata A, Altei F, Siani A. Suspected ureteral colic: primary helical CT versus selective helical CT after unenhanced radiography and sonography. Am J Roentgenol 2002;178:379-86.
14. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005;115:2598-608.
15. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992;327(16):1141-52.
16. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 1997;51(3):894-900.
17. Levy FL, Adams-Huet B, Pak CY. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995;98:50-9.
18. Pak CY. Medical prevention of renal stone disease. Nephron 1999;81(suppl. 1):60-5.
19. Lotan Y, Cadeddu JA, Roerhborn CG, Pak CY, Pearle MS. Cost effectiveness of medical management strategies for nephrolithiasis. J Urol 2004;172:2275-81.
20. Pak CY, Peterson R, Poindexter JR. Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis. J Urol 2001;165:378-81.
21. Parks JH, Goldfisher E, Asplin JR, Col FL. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol 2002;167:1607-12.
22. Yagisawa T, Chandhoke PS, Fan J. Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis. J Urol 1999;161:1449-52.
23. Curhan GC, Willet WC, Speizer FE, Stampfer MJ Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 2001;59:2290.
24. Soriano JR. Renal tubular acidosis: The clinical entity. J Am Soc Nephrol 2002;13:2160-70.
25. Vezzoli G, Soldati L, Arcidiacono T, Terranegra A, Biasion R, Russo CR, et al. Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int 2005;67:2006-14.
26. Asplin JR, Bauer KA, Kinder J, Muller G, Coe BJ, Parks JH, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 2003;63:662-9.
27. Gomes SA, Lage A, Lazaretti-Castro M, Vieira JG, Heilberg IP. Response to oral calcium load in nephrolithiasis patients with fluctuating parathyroid hormone and ionized calcium levels. Braz J Med Biol Res 2004;37(9):1379-88.
28. nd ed. Chicago: Year Book Medical Publishers, 1998. pp. 109-10.
29. Heilberg IP. Hypercalciuria. In: Martini L (ed). Encyclopedia of endocrine diseases. Vol 2. San Diego: Academic Press, 2004. pp. 530-6.
30. Hodkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg 1958;46:10-8.
31. Flocks RH. Calcium and phosphorus excretion in the urine of patients with renal or ureteral calculi. JAMA 1939;13:1466-71.
32. Albright F, Henneman P, Benedict PH, Forbes AP. Idiopathic hypercalciuria: A preliminary report. Proc Roy Soc Med 1953;46:1077-81.
33. Pak CYC, Kaplan R, Bone H, Townsend J, Waters O. A simple test for the diagnosis of absorptive, resorptive and renal hypercalciuria. N Engl J Med 1975;292:497-500.
34. Heilberg IP, Martini LA, Draibe SA, Ajzen H, Ramos OL, Schor N. Sensitivity to calcium intake in calcium stone forming patients. Nephron 1996;73:145-53.
35. Martini LA, Heilberg IP, Cuppari L, Medeiros FAM, Draibe SA, Ajzen H, et al. Dietary habits of calcium stone formers. Braz J Med Biol Res 1993;26:805-12.
36. Coe FL, Favus MJ, Crockett T, Strauss AL, Parks JH, Porat A, et al. Effects of low calcium diet on urine calcium excretion, parathyroid function and serum 1, 25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982;72:25-32.
37. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 2003;14:1082-95.
38. Fuss M, Gillet C, Simon J, Vandewalle JC, Schoutens A, Bergmann P. Bone mineral content in idiopathic renal stone disease and in primary hyperparathyroidism. Eur Urol 1983;9(1):32-4.
39. Pacifici R, Rothstein M, Rifas L, Lau KH, Baylink DJ, Avioli LV, et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990;71:138-45.
40. Bataille P, Achard JM, Fournier A, Boudailliez B, Westeel PF, el Esper N, et al. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 1991;39:1193-205.
41. Pietschmann F, Breslau NA, Pak CY. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992;7:1383-8.
42. Jaeger P, Lippuner K, Casez JP, Hess B, Ackermann D, Hug C. Low bone mass in idiopathic renal stone formers: magnitude and significance. J Bone Miner Res 1994;9:1525-32.
43. Weisinger JR. New insights into the pathogenesis of idiopathic hypercalciuria: the role of bone. Kidney Int 1996;49:1507-18.
44. Ghazali A, Fuentes V, Desaint C, Bataille P, Westeel A, Brazier M, et al. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab 1997;82:32-8.
45. Giannini S, Nobile M, Sartori L, Calo L, Tasca A, Dalle Carbonare L, et al. Bone density and skeletal metabolism are altered in idiopathic hypercalciuria. Clin Nephrol 1998;50(2):94-100.
46. Trinchieri A, Nespoli R, Ostini F, Rovera F, Zanetti G, Pisani E. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 1998;159:654-7.
47. Heilberg IP, Martini LA, Szejnfeld VL, Carvalho AB, Draibe SA, Ajzen H, et al. Bone disease in calcium stone forming patients. Clin Nephrol 1994;42:175-82.
48. Misael da Silva AM, dos Reis LM, Pereira RC, Futata E, Branco-Martins CT, Noronha IL, et al. Bone involvement in idiopathic hypercalciuria. Clin Nephrol 2002;57:183-91.
49. Malluche HH, Tschoepe W, Ritz E, Meyer-Sabellek W, Massry SG. Abnormal bone histology in idiopathic hypercalciuria. J Clin Endocrinol Metab 1980;50:654-8.
50. Steiniche T, Mosekilde L, Christensen MS, Melsen F. A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria. APMIS 1989;97:309-16.
51. Melton LJ 3rd, Crowson CS, Khosla S, Wilson DM, O'Fallon WM. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 1998;53:459-64.
52. Lauderdale DS, Thisted RA, Wen M, Favus MJ. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res 2001;16:1893-8.
53. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 2004;65(2):386-92.
54. Maalouf NM, Cameron MA, Moe OW, Sakhaee K. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 2004;13(2):181-9.
55. McConnell N, Campbell S, Gillanders I, Rolton H, Danesh B. Risk factors for developing renal stones in inflammatory bowel disease. BJU Int 2002;89(9):835-41.
56. Nishiura JL, Mendonça COG, Schor N, Heilberg IP. Effect of calcium intake on urinary oxalate excretion in calcium stone-forming patients. Braz J Med Biol Res 2002;35:669-75.
57. Cheidde L, Vieira TC, Lima PR, Saad ST, Heilberg IP. A novel mutation in the anion exchanger 1 gene is associated with familial distal renal tubular acidosis and nephrocalcinosis. Pediatrics 2003;112(6 Pt 1):1361-7.
58. Shekarriz B, Stoller ML. Cystinuria and other noncalcareous calculi. Endocrinol Metab Clin North Am 2002;31(4):951-77.
59. Curhan GC, Willet WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1983;328:833-8.
60. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346(2):77-84.
61. Heilberg IP. Update on dietary recommendations and medical treatment of renal stone disease. Nephrol Dial Tranplant 2000;15:117-23.
62. de O G Mendonça C, Martini LA, Baxmann AC, Nishiura JL, Cuppari L, Sigulem DM, et al. Effects of an oxalate load on urinary oxalate excretion in calcium stone formers. J Ren Nutr 2003;13(1):39-46.
63. Baxmann AC, de O G Mendonça C, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 2003;63(3):1066-71.
64. Martini LA, Cuppari L, Colugnati FAB, Sigulem DM, Szejnfeld VL, Schor N, et al. High sodium chloride intake is associated with low bone density in calcium stone forming patients. Clin Nephrol 2000;54(2):85-93.
65. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 2005;115(6):1651-8.
66. Goldfarb DS. Reconsideration of the 1998 NIH Consensus Statement on prevention and treatment of kidney stones: are the recommendations out of date? Rev Urol 2002;4(2):53-60.